Recent results from the CLOSURE I PFO clinical study, released last month at the American Heart Association (AHA; Dallas) annual meeting by NMT Medical (Chicago) (Medical Device Daily, Nov. 17, 2010) aren't stopping W. L. Gore & Associates (Flagstaff, Arizona) in its efforts to press forward with its REDUCE clinical study, the company said. (Medical Device Daily)
A new case report published Nov. 30 in Circulation could give cardiologists new insight in describing the association of stent thrombosis with lipid core plaque. Researchers used InfraReDx's (Burlington, Massachusetts) LipiScan Coronary Imaging System to detect acute stent thrombosis with a disrupted lipid core plaque in a patient. (Medical Device Daily)
Over-anxious physicians are being cited as one reason why Abiomed (Danvers, Massachusetts) is abruptly ending its PROTECT II study of Impella, which was designed to study major adverse events in high-risk percutaneous coronary intervention (PCI) patients who received support with Impella 2.5 vs. intra-aortic balloon (IAB) pumps. (Medical Device Daily)
